Interestingly, we found that the PM duration in HCC patients with high SOCS5 expression had a highly significant effect on patient outcomes, but the PM duration in HCC patients with low SOCS5 expression did not affect patient outcomes. This evidence concerns the gene SOCS5 and hepatocellular carcinoma.